Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT Trial)

NCT00417222 is registered in ClinicalTrials.gov with Tohoku University as lead sponsor.

NCT NCT00417222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT Trial)
Lead sponsor
Tohoku University
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2013
Enrollment
1,145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure